Vetbiologics is an innovative veterinary regenerative medicine company committed to providing veterinarians with the ability to provide the best possible stem cell therapy to dogs, cats and horses at the point-of-care. VetBiologics provides veterinarians with the ability to isolate regenerative stem cells from a patient’s own adipose (fat) tissue directly on-site within their own clinic or where a patient is located. Regenerative stem cells isolated from adipose tissue have been shown in studies to be effective in treating animals suffering from osteoarthritis, joint diseases, tendon injuries and heart disorders, among other conditions. Vetbiologics has a highly experienced management team with over 20 years combined experience in developing stem cell therapeutics for both human and animal use. The Stemlogix team has experience in setting up full scale cGMP stem cell manufacturing facilities, stem cell product development and enhancement, developing point-of-care cell production systems, developing culture expanded stem cell production systems, FDA compliance, directing clinical and preclinical studies with multiple cell types for multiple indications, and more.
